LPEHR results in long and durable relief of symptoms and improvement in QOL with PR or SIS. There does not appear to be a higher rate of complications or side effects with biologic mesh, but its benefit in reducing HH recurrence diminishes at long-term follow-up (more than 5 years postoperatively) or earlier.
No takes yet. Share an insight, caveat, or question.
Oelschlager et al. (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: